_id
6911c58cccc777a4e85d6505
Ticker
HLNCF
Name
Haleon plc
Exchange
PINK
Address
The Heights, Weybridge, United Kingdom, KT13 0NY
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.haleon.com
Description
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Last Close
5.2
Volume
28629
Current Price
4.99
Change
-0.21
Last Updated
2026-01-04T14:31:39.450Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
43060330496
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9984999999999999
Sentiment Sources
2
Current Quarter
2025-06-30
Revenue
2740000000
Cost Of Revenue
972500000
Gross Profit
1767500000
Operating Expenses
1166000000
Operating Income
601500000
Interest Expense
64500000
Pretax Income
537500000
Net Income
403000000
Eps
0.04446160635481024
Dividends Per Share
-207500000
Shares Outstanding
8906058549
Income Tax Expense
131000000
EBITDA
696500000
Operating Margin
21.95255474452555
Total Other Income Expense Net
-64000000
Cash
676000000
Short Term Investments
-
Receivables
2144000000
Inventories
1130000000
Total Current Assets
4144000000
Property Plant Equipment
1869000000
Total Assets
31828000000
Payables
3562000000
Short Term Debt
813000000
Long Term Debt
7554000000
Total Liabilities
15830000000
Equity
15941000000
Bs_currency_symbol
GBP
Depreciation
88000000
Change In Working Capital
-122500000
Cash From Operations
513500000
Capital Expenditures
48000000
Cash From Investing
-38000000
Cash From Financing
-1258500000
Net Change In Cash
-
Cf_currency_symbol
-
PE
21.7727
PB
2.837297534659055
ROE
2.5280722664826545
ROA
1.2661807213774035
FCF
465500000
Fcf Percent
0.16989051094890512
Piotroski FScore
4
Health Score
66
Deep Value Investing Score
4.5
Defensive Investing Score
5.5
Dividend Investing Score
5
Economic Moat Investing Score
7.8
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
6
Net Net Investing Score
2.5
Quality Investing Score
7
Value Investing Score
5.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
2740000000
Quarters > 0 > income Statement > cost Of Revenue
972500000
Quarters > 0 > income Statement > gross Profit
1767500000
Quarters > 0 > income Statement > operating Expenses
1166000000
Quarters > 0 > income Statement > operating Income
601500000
Quarters > 0 > income Statement > interest Expense
64500000
Quarters > 0 > income Statement > pretax Income
537500000
Quarters > 0 > income Statement > net Income
403000000
Quarters > 0 > income Statement > eps
0.04446160635481024
Quarters > 0 > income Statement > dividends Per Share
-207500000
Quarters > 0 > income Statement > shares Outstanding
9064000000
Quarters > 0 > income Statement > income Tax Expense
131000000
Quarters > 0 > income Statement > EBITDA
696500000
Quarters > 0 > income Statement > operating Margin
21.95255474452555
Quarters > 0 > income Statement > total Other Income Expense Net
-64000000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
676000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2144000000
Quarters > 0 > balance Sheet > inventories
1130000000
Quarters > 0 > balance Sheet > total Current Assets
4144000000
Quarters > 0 > balance Sheet > property Plant Equipment
1869000000
Quarters > 0 > balance Sheet > total Assets
31828000000
Quarters > 0 > balance Sheet > payables
3562000000
Quarters > 0 > balance Sheet > short Term Debt
813000000
Quarters > 0 > balance Sheet > long Term Debt
7554000000
Quarters > 0 > balance Sheet > total Liabilities
15830000000
Quarters > 0 > balance Sheet > equity
15941000000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
403000000
Quarters > 0 > cash Flow > depreciation
88000000
Quarters > 0 > cash Flow > change In Working Capital
-122500000
Quarters > 0 > cash Flow > cash From Operations
513500000
Quarters > 0 > cash Flow > capital Expenditures
48000000
Quarters > 0 > cash Flow > cash From Investing
-38000000
Quarters > 0 > cash Flow > cash From Financing
-1258500000
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.04446160635481024
Quarters > 0 > ratios > PB
2.837297534659055
Quarters > 0 > ratios > ROE
2.5280722664826545
Quarters > 0 > ratios > ROA
1.2661807213774035
Quarters > 0 > ratios > FCF
465500000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.16989051094890512
Quarters > 0 > health Score
66
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
2740000000
Quarters > 1 > income Statement > cost Of Revenue
972500000
Quarters > 1 > income Statement > gross Profit
1767500000
Quarters > 1 > income Statement > operating Expenses
1166000000
Quarters > 1 > income Statement > operating Income
601500000
Quarters > 1 > income Statement > interest Expense
64500000
Quarters > 1 > income Statement > pretax Income
537500000
Quarters > 1 > income Statement > net Income
403000000
Quarters > 1 > income Statement > eps
0.04446160635481024
Quarters > 1 > income Statement > dividends Per Share
-207500000
Quarters > 1 > income Statement > shares Outstanding
9064000000
Quarters > 1 > income Statement > income Tax Expense
131000000
Quarters > 1 > income Statement > EBITDA
696500000
Quarters > 1 > income Statement > operating Margin
21.95255474452555
Quarters > 1 > income Statement > total Other Income Expense Net
-64000000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
676000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2144000000
Quarters > 1 > balance Sheet > inventories
1130000000
Quarters > 1 > balance Sheet > total Current Assets
4144000000
Quarters > 1 > balance Sheet > property Plant Equipment
1869000000
Quarters > 1 > balance Sheet > total Assets
31828000000
Quarters > 1 > balance Sheet > payables
3562000000
Quarters > 1 > balance Sheet > short Term Debt
866000000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
15830000000
Quarters > 1 > balance Sheet > equity
15941000000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
403000000
Quarters > 1 > cash Flow > depreciation
88000000
Quarters > 1 > cash Flow > change In Working Capital
-122500000
Quarters > 1 > cash Flow > cash From Operations
513500000
Quarters > 1 > cash Flow > capital Expenditures
48000000
Quarters > 1 > cash Flow > cash From Investing
-38000000
Quarters > 1 > cash Flow > cash From Financing
-1258500000
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.04446160635481024
Quarters > 1 > ratios > PB
2.837297534659055
Quarters > 1 > ratios > ROE
2.5280722664826545
Quarters > 1 > ratios > ROA
1.2661807213774035
Quarters > 1 > ratios > FCF
465500000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.16989051094890512
Quarters > 1 > health Score
66
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
2759000000
Quarters > 2 > income Statement > cost Of Revenue
1231000000
Quarters > 2 > income Statement > gross Profit
1528000000
Quarters > 2 > income Statement > operating Expenses
1178000000
Quarters > 2 > income Statement > operating Income
350000000
Quarters > 2 > income Statement > interest Expense
111000000
Quarters > 2 > income Statement > pretax Income
288000000
Quarters > 2 > income Statement > net Income
231000000
Quarters > 2 > income Statement > eps
0.025075041057717545
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
9212347827
Quarters > 2 > income Statement > income Tax Expense
66000000
Quarters > 2 > income Statement > EBITDA
448000000
Quarters > 2 > income Statement > operating Margin
12.685755708590069
Quarters > 2 > income Statement > total Other Income Expense Net
-62000000
Quarters > 2 > income Statement > currency_symbol
GBP
Quarters > 2 > balance Sheet > cash
2195000000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1904000000
Quarters > 2 > balance Sheet > inventories
1190000000
Quarters > 2 > balance Sheet > total Current Assets
5718000000
Quarters > 2 > balance Sheet > property Plant Equipment
1921000000
Quarters > 2 > balance Sheet > total Assets
34315000000
Quarters > 2 > balance Sheet > payables
1973000000
Quarters > 2 > balance Sheet > short Term Debt
1487000000
Quarters > 2 > balance Sheet > long Term Debt
8542000000
Quarters > 2 > balance Sheet > total Liabilities
18091000000
Quarters > 2 > balance Sheet > equity
16166000000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
231000000
Quarters > 2 > cash Flow > depreciation
49000000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
GBP
Quarters > 2 > ratios > PE
0.025075041057717545
Quarters > 2 > ratios > PB
2.843598642628356
Quarters > 2 > ratios > ROE
1.4289249041197576
Quarters > 2 > ratios > ROA
0.6731749963572782
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
49
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
2780000000
Quarters > 3 > income Statement > cost Of Revenue
1032000000
Quarters > 3 > income Statement > gross Profit
1748000000
Quarters > 3 > income Statement > operating Expenses
1043000000
Quarters > 3 > income Statement > operating Income
705000000
Quarters > 3 > income Statement > interest Expense
90000000
Quarters > 3 > income Statement > pretax Income
626000000
Quarters > 3 > income Statement > net Income
485000000
Quarters > 3 > income Statement > eps
0.05264673122507796
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
9212347827
Quarters > 3 > income Statement > income Tax Expense
127000000
Quarters > 3 > income Statement > EBITDA
752750000
Quarters > 3 > income Statement > operating Margin
25.359712230215827
Quarters > 3 > income Statement > total Other Income Expense Net
-79000000
Quarters > 3 > income Statement > currency_symbol
GBP
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-16707000000
Quarters > 3 > balance Sheet > equity
16707000000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
485000000
Quarters > 3 > cash Flow > depreciation
47750000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
GBP
Quarters > 3 > ratios > PE
0.05264673122507796
Quarters > 3 > ratios > PB
2.751518265202011
Quarters > 3 > ratios > ROE
2.9029748009816245
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
64
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
11233000000
Annuals > 0 > income Statement > cost Of Revenue
4409000000
Annuals > 0 > income Statement > gross Profit
6824000000
Annuals > 0 > income Statement > operating Expenses
4618000000
Annuals > 0 > income Statement > operating Income
2206000000
Annuals > 0 > income Statement > interest Expense
394000000
Annuals > 0 > income Statement > pretax Income
1910000000
Annuals > 0 > income Statement > net Income
1442000000
Annuals > 0 > income Statement > eps
0.15699999999651595
Annuals > 0 > income Statement > dividends Per Share
-570000000
Annuals > 0 > income Statement > shares Outstanding
9184713376
Annuals > 0 > income Statement > income Tax Expense
435000000
Annuals > 0 > income Statement > EBITDA
2628000000
Annuals > 0 > income Statement > operating Margin
19.638564942579897
Annuals > 0 > income Statement > total Other Income Expense Net
-296000000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
2195000000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1904000000
Annuals > 0 > balance Sheet > inventories
1190000000
Annuals > 0 > balance Sheet > total Current Assets
5718000000
Annuals > 0 > balance Sheet > property Plant Equipment
1921000000
Annuals > 0 > balance Sheet > total Assets
34315000000
Annuals > 0 > balance Sheet > payables
1973000000
Annuals > 0 > balance Sheet > short Term Debt
1487000000
Annuals > 0 > balance Sheet > long Term Debt
8542000000
Annuals > 0 > balance Sheet > total Liabilities
18091000000
Annuals > 0 > balance Sheet > equity
16166000000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
1475000000
Annuals > 0 > cash Flow > depreciation
324000000
Annuals > 0 > cash Flow > change In Working Capital
206000000
Annuals > 0 > cash Flow > cash From Operations
2301000000
Annuals > 0 > cash Flow > capital Expenditures
318000000
Annuals > 0 > cash Flow > cash From Investing
528000000
Annuals > 0 > cash Flow > cash From Financing
-1537000000
Annuals > 0 > cash Flow > net Change In Cash
1213000000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
0.15699999999651595
Annuals > 0 > ratios > PB
2.721438641039218
Annuals > 0 > ratios > ROE
8.91995546208091
Annuals > 0 > ratios > ROA
4.202243916654524
Annuals > 0 > ratios > FCF
1983000000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.1765334282916407
Annuals > 0 > health Score
68
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
11302000000
Annuals > 1 > income Statement > cost Of Revenue
4341000000
Annuals > 1 > income Statement > gross Profit
6961000000
Annuals > 1 > income Statement > operating Expenses
4965000000
Annuals > 1 > income Statement > operating Income
1996000000
Annuals > 1 > income Statement > interest Expense
414000000
Annuals > 1 > income Statement > pretax Income
1628000000
Annuals > 1 > income Statement > net Income
1049000000
Annuals > 1 > income Statement > eps
0.1132462485155997
Annuals > 1 > income Statement > dividends Per Share
-388000000
Annuals > 1 > income Statement > shares Outstanding
9263000000
Annuals > 1 > income Statement > income Tax Expense
517000000
Annuals > 1 > income Statement > EBITDA
2351000000
Annuals > 1 > income Statement > operating Margin
17.660591045832597
Annuals > 1 > income Statement > total Other Income Expense Net
-368000000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
1044000000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1352000000
Annuals > 1 > balance Sheet > inventories
1408000000
Annuals > 1 > balance Sheet > total Current Assets
4818000000
Annuals > 1 > balance Sheet > property Plant Equipment
1902000000
Annuals > 1 > balance Sheet > total Assets
34055000000
Annuals > 1 > balance Sheet > payables
1855000000
Annuals > 1 > balance Sheet > short Term Debt
656000000
Annuals > 1 > balance Sheet > long Term Debt
8800000000
Annuals > 1 > balance Sheet > total Liabilities
17326000000
Annuals > 1 > balance Sheet > equity
16606000000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
1111000000
Annuals > 1 > cash Flow > depreciation
309000000
Annuals > 1 > cash Flow > change In Working Capital
-107000000
Annuals > 1 > cash Flow > cash From Operations
2100000000
Annuals > 1 > cash Flow > capital Expenditures
336000000
Annuals > 1 > cash Flow > cash From Investing
-134000000
Annuals > 1 > cash Flow > cash From Financing
-1568000000
Annuals > 1 > cash Flow > net Change In Cash
383000000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
0.1132462485155997
Annuals > 1 > ratios > PB
2.6719119595326988
Annuals > 1 > ratios > ROE
6.316993857641815
Annuals > 1 > ratios > ROA
3.0803112611951255
Annuals > 1 > ratios > FCF
1764000000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.15607857016457263
Annuals > 1 > health Score
63
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
10858000000
Annuals > 2 > income Statement > cost Of Revenue
4281000000
Annuals > 2 > income Statement > gross Profit
6577000000
Annuals > 2 > income Statement > operating Expenses
4752000000
Annuals > 2 > income Statement > operating Income
1825000000
Annuals > 2 > income Statement > interest Expense
278000000
Annuals > 2 > income Statement > pretax Income
1618000000
Annuals > 2 > income Statement > net Income
1060000000
Annuals > 2 > income Statement > eps
0.11473103149691526
Annuals > 2 > income Statement > dividends Per Share
2682000000
Annuals > 2 > income Statement > shares Outstanding
9239000000
Annuals > 2 > income Statement > income Tax Expense
499000000
Annuals > 2 > income Statement > EBITDA
2183000000
Annuals > 2 > income Statement > operating Margin
16.807883588137777
Annuals > 2 > income Statement > total Other Income Expense Net
-207000000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
684000000
Annuals > 2 > balance Sheet > short Term Investments
78000000
Annuals > 2 > balance Sheet > receivables
1881000000
Annuals > 2 > balance Sheet > inventories
1348000000
Annuals > 2 > balance Sheet > total Current Assets
4059000000
Annuals > 2 > balance Sheet > property Plant Equipment
1899000000
Annuals > 2 > balance Sheet > total Assets
34815000000
Annuals > 2 > balance Sheet > payables
1835000000
Annuals > 2 > balance Sheet > short Term Debt
437000000
Annuals > 2 > balance Sheet > long Term Debt
10003000000
Annuals > 2 > balance Sheet > total Liabilities
18358000000
Annuals > 2 > balance Sheet > equity
16331000000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
1119000000
Annuals > 2 > cash Flow > depreciation
287000000
Annuals > 2 > cash Flow > change In Working Capital
181000000
Annuals > 2 > cash Flow > cash From Operations
2063000000
Annuals > 2 > cash Flow > capital Expenditures
328000000
Annuals > 2 > cash Flow > cash From Investing
-8784000000
Annuals > 2 > cash Flow > cash From Financing
6911000000
Annuals > 2 > cash Flow > net Change In Cash
205000000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
0.11473103149691526
Annuals > 2 > ratios > PB
2.7098652868777173
Annuals > 2 > ratios > ROE
6.4907231645337085
Annuals > 2 > ratios > ROA
3.0446646560390636
Annuals > 2 > ratios > FCF
1735000000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.1597900165776386
Annuals > 2 > health Score
63
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
9545000000
Annuals > 3 > income Statement > cost Of Revenue
3595000000
Annuals > 3 > income Statement > gross Profit
5950000000
Annuals > 3 > income Statement > operating Expenses
4312000000
Annuals > 3 > income Statement > operating Income
1638000000
Annuals > 3 > income Statement > interest Expense
16000000
Annuals > 3 > income Statement > pretax Income
1636000000
Annuals > 3 > income Statement > net Income
1390000000
Annuals > 3 > income Statement > eps
0.15052129372054399
Annuals > 3 > income Statement > dividends Per Share
1148000000
Annuals > 3 > income Statement > shares Outstanding
9234573831
Annuals > 3 > income Statement > income Tax Expense
197000000
Annuals > 3 > income Statement > EBITDA
2211000000
Annuals > 3 > income Statement > operating Margin
17.16081718177056
Annuals > 3 > income Statement > total Other Income Expense Net
-2000000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
414000000
Annuals > 3 > balance Sheet > short Term Investments
1000000
Annuals > 3 > balance Sheet > receivables
3825000000
Annuals > 3 > balance Sheet > inventories
951000000
Annuals > 3 > balance Sheet > total Current Assets
5251000000
Annuals > 3 > balance Sheet > property Plant Equipment
1662000000
Annuals > 3 > balance Sheet > total Assets
34451000000
Annuals > 3 > balance Sheet > payables
1369000000
Annuals > 3 > balance Sheet > short Term Debt
904000000
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
7971000000
Annuals > 3 > balance Sheet > equity
26355000000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
1439000000
Annuals > 3 > cash Flow > depreciation
268000000
Annuals > 3 > cash Flow > change In Working Capital
-152000000
Annuals > 3 > cash Flow > cash From Operations
1356000000
Annuals > 3 > cash Flow > capital Expenditures
298000000
Annuals > 3 > cash Flow > cash From Investing
-33000000
Annuals > 3 > cash Flow > cash From Financing
-1236000000
Annuals > 3 > cash Flow > net Change In Cash
82000000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.15052129372054399
Annuals > 3 > ratios > PB
1.6783763479601594
Annuals > 3 > ratios > ROE
5.274141529121609
Annuals > 3 > ratios > ROA
4.034715973411513
Annuals > 3 > ratios > FCF
1058000000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.1108433734939759
Annuals > 3 > health Score
67
Valuation > metrics > PE
21.7727
Valuation > metrics > PB
2.837297534659055
Valuation > final Score
100
Valuation > verdict
Fair
Profitability > metrics > ROE
2.5280722664826545
Profitability > metrics > ROA
9.724903474903474
Profitability > metrics > Net Margin
0.1470802919708029
Profitability > final Score
56
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.9930368232858666
Risk > metrics > Interest Coverage
9.325581395348838
Risk > final Score
85
Risk > verdict
Low
Liquidity > metrics > Current Ratio
0.9472
Liquidity > metrics > Quick Ratio
0.6889142857142857
Liquidity > final Score
44
Liquidity > verdict
Weak
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
56
Prev Profitabilities > 1
28
Prev Profitabilities > 2
47
Prev Risks > 0
85
Prev Risks > 1
43
Prev Risks > 2
91
Prev Liquidities > 0
44
Prev Liquidities > 1
91
Prev Liquidities > 2
50
Updated At
2026-01-20T21:58:29.840Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2022-12-31
Earnings History > 1 > report Date
2023-03-01
Earnings History > 1 > date
2022-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
3.37
Earnings History > 1 > eps Estimate
5
Earnings History > 1 > eps Difference
-1.63
Earnings History > 1 > surprise Percent
-32.6
Earnings History > 2 > period
2022-09-30
Earnings History > 2 > report Date
2022-11-09
Earnings History > 2 > date
2022-09-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
5.43
Earnings History > 2 > eps Estimate
4.76
Earnings History > 2 > eps Difference
0.67
Earnings History > 2 > surprise Percent
14.0756
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHaleon: Fairly Priced Given Limited Growth Drivers (NYSE:HLN) Seeking Alpha
Read more →Haleon’s Steady Brands Face Near-Term Hurdles And Long-Term Promise Finimize
Read more →Showing 2 of 7
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Haleon plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2022-12-31
EPS Actual
3.37
EPS Estimate
5
EPS Difference
-1.63
Surprise Percent
-32.6%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.